Phase III, double-blind, placebo-controlled, 2-cohort, randomized study of saruparib (AZD5305) in combination with new hormonal agents in patients with metastatic castration-sensitive prostate cancer with and without homologous recombination repair mutation (EvoPAR-Prostate01)

Chi K. N., Agarwal N., Armstrong A. J., Hellmis E., Schluermann F., Ueruen Y., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, sa.16, 2024 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Özet
  • Basım Tarihi: 2024
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database
  • Ankara Üniversitesi Adresli: Hayır